Anika Therapeutics Inc.
NASDAQ:ANIK 4:00:00 PM EDT
| Market Cap (Intraday) | 403.12M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 918.33 |
| 10-Day MA | $27.39 |
| 50-Day MA | $30.01 |
| 200-Day MA | $26.52 |
Anika Therapeutics Inc. Stock, NASDAQ:ANIK
32 Wiggins Avenue, Bedford, Massachusetts 01730
United States of America
Phone: +1.781.457.9000
Number of Employees: 345
Description
Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.